Global Standardized Financials

355.48 1.37(0.39%)05/17/2024
West Pharmaceutical Services, Inc. (WST)

Income Statement
(Values in USD Thousands)
 2024-03-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31
Net Income115,300161,300155,100140,000
Revenue695,400747,400753,800716,600
Cost Of Revenue465,200459,100462,400445,300
gross Profit230,200288,300291,400271,300
Operating Expenses107,400105,400104,900116,000
Selling General and Administrative Expenses86,70089,00088,40086,000
Research and Development Expenses17,60016,40016,50017,100
Other Expenses-3,100-1,800-3,90012,900
Cost And Expenses572,600564,500567,300561,300
Operating Income122,800177,300182,500155,300
Interest Income6,200-8,8005,0004,800
Income Tax Expense16,40029,40034,80023,600
Income Before Tax127,400187,000184,900157,900
Earning Per Share Basic1.572.172.081.88
Earning Per Share Diluted1.552.142.061.85
weighted Average Shares Outstanding73,50074,30074,30074,500
weighted Average Shares Outstanding (Diluted)74,30075,30075,40075,700
Gross Margin0.330.390.390.38
EBIT Margin0.230.290.290.26
Profit Margin0.170.220.210.20
EBITDA158,400218,600220,600186,900
Earning Before Tax Margin0.180.250.250.22